Michael Stabin

811 total citations
18 papers, 603 citations indexed

About

Michael Stabin is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Materials Chemistry. According to data from OpenAlex, Michael Stabin has authored 18 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Radiology, Nuclear Medicine and Imaging, 4 papers in Pulmonary and Respiratory Medicine and 3 papers in Materials Chemistry. Recurrent topics in Michael Stabin's work include Radiopharmaceutical Chemistry and Applications (12 papers), Medical Imaging Techniques and Applications (5 papers) and Radiation Dose and Imaging (3 papers). Michael Stabin is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (12 papers), Medical Imaging Techniques and Applications (5 papers) and Radiation Dose and Imaging (3 papers). Michael Stabin collaborates with scholars based in United States, Brazil and France. Michael Stabin's co-authors include Janet F. Eary, Cheryl Vernon, Conor D. Collins, Matthew Baker, F R Appelbaum, Stephen H. Petersdorf, William D. Erwin, Adam Farmer, Richard E. Bélanger and Thomas E. Witzig and has published in prestigious journals such as European Journal of Nuclear Medicine and Molecular Imaging, Radiation Research and Journal of Nuclear Medicine.

In The Last Decade

Michael Stabin

18 papers receiving 573 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Stabin United States 10 441 186 155 115 89 18 603
Isabella Palumbo Italy 15 311 0.7× 225 1.2× 157 1.0× 90 0.8× 133 1.5× 61 665
C. Laubenbacher Germany 11 703 1.6× 349 1.9× 164 1.1× 73 0.6× 188 2.1× 17 1.0k
Gregor J. Förster Germany 11 270 0.6× 103 0.6× 83 0.5× 78 0.7× 60 0.7× 18 482
Galina Iosilevsky Israel 13 279 0.6× 141 0.8× 102 0.7× 88 0.8× 109 1.2× 26 547
Nobukazu Takahashi Japan 14 342 0.8× 228 1.2× 53 0.3× 29 0.3× 147 1.7× 35 675
Alexander Bruskin Russia 14 356 0.8× 61 0.3× 147 0.9× 66 0.6× 89 1.0× 33 560
Jan Wondergem Netherlands 13 264 0.6× 104 0.6× 81 0.5× 39 0.3× 160 1.8× 17 576
Lebriz Uslu Türkiye 13 307 0.7× 184 1.0× 73 0.5× 33 0.3× 90 1.0× 52 549
Gregory M. Richards United States 13 174 0.4× 353 1.9× 102 0.7× 57 0.5× 162 1.8× 15 632
Sandra Rea Italy 12 338 0.8× 213 1.1× 175 1.1× 28 0.2× 184 2.1× 25 702

Countries citing papers authored by Michael Stabin

Since Specialization
Citations

This map shows the geographic impact of Michael Stabin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Stabin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Stabin more than expected).

Fields of papers citing papers by Michael Stabin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Stabin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Stabin. The network helps show where Michael Stabin may publish in the future.

Co-authorship network of co-authors of Michael Stabin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Stabin. A scholar is included among the top collaborators of Michael Stabin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Stabin. Michael Stabin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wall, Jonathan S., Emily B. Martin, Aaron N. Endsley, et al.. (2021). First in Human Evaluation and Dosimetry Calculations for Peptide 124I-p5+14—a Novel Radiotracer for the Detection of Systemic Amyloidosis Using PET/CT Imaging. Molecular Imaging and Biology. 24(3). 479–488. 16 indexed citations
2.
Stabin, Michael & Adam Farmer. (2012). OLINDA/EXM 2.0: The new generation dosimetry modeling code. 53. 585–585. 27 indexed citations
3.
Arlicot, Nicolas, Sylvie Chalon, Johnny Vercouillie, et al.. (2012). Radiation dosimetry of [18F]DPA-714, a potential PET biomarker for neuroinflammation. 53. 1502–1502. 1 indexed citations
4.
Barrett, J. H., Tamara L. Anderson, Shawn Hillier, et al.. (2008). Determination of the ability of 111In Onalta (edotreotide) to be used as an imaging surrogate for the accurate prediction of 90Y Onalta radiation absorbed dose. 49. 1 indexed citations
5.
Cremonesi, Marta, Mahila Ferrari, Chiara Maria Grana, et al.. (2007). High-Dose Radioimmunotherapy with 90Y-Ibritumomab Tiuxetan: Comparative Dosimetric Study for Tailored Treatment. Journal of Nuclear Medicine. 48(11). 1871–1879. 36 indexed citations
6.
Bérard, P., et al.. (2007). Review of standards of protection for pregnant workers and their offspring. Radiation Protection Dosimetry. 127(1-4). 19–22. 8 indexed citations
7.
Breitz, Hazel B., Richard E. Wendt, Michael Stabin, et al.. (2006). 166Ho-DOTMP radiation-absorbed dose estimation for skeletal targeted radiotherapy.. PubMed. 47(3). 534–42. 47 indexed citations
8.
Lipsztein, J.L., et al.. (2003). Retrospective study of the iodine-131 contamination of workers of a radiopharmaceutical industry. Radiation Protection Dosimetry. 103(4). 331–339. 1 indexed citations
9.
Campos, Luís & Michael Stabin. (2002). Internal Dosimetry for Radiation Therapy in Coronary Arteries. Radiation Protection Dosimetry. 101(1). 423–426. 2 indexed citations
10.
Stabin, Michael, et al.. (2002). Intravascular brachytherapy to prevent restenosis: dosimetric considerations.. PubMed. 48(5). 429–39. 3 indexed citations
11.
Wiseman, Gregory A., Christine A. White, Michael Stabin, et al.. (2000). Phase I/II 90 Y-Zevalin (yttrium-90 ibritumomab tiuxetan, IDEC-Y2B8) radioimmunotherapy dosimetry results in relapsed or refractory non-Hodgkin's lymphoma. European Journal of Nuclear Medicine and Molecular Imaging. 27(7). 766–777. 189 indexed citations
12.
Kotzerke, J., et al.. (1998). [Dosimetry fundamentals of endovascular therapy using Re-188 for the prevention of restenosis after angioplasty].. PubMed. 37(2). 68–72. 10 indexed citations
13.
Stabin, Michael, et al.. (1998). Dosimetrische Grundlagen für die endo vaskuläre Therapie mit Re-188 zur Prävention der Restenose nach Angioplastie. Nuklearmedizin - NuclearMedicine. 37(2). 68–72. 9 indexed citations
14.
Stabin, Michael. (1997). Deposition, Retention and Dosimetry of Inhaled Radioactive Substances. Radiation Research. 148(4). 403–403. 29 indexed citations
15.
Seibyl, John, Elizabeth A. Wallace, E. O. Smith, et al.. (1994). Whole-body biodistribution, radiation absorbed dose and brain SPECT imaging with iodine-123-beta-CIT in healthy human subjects.. PubMed. 35(5). 764–70. 38 indexed citations
16.
Eary, Janet F., Conor D. Collins, Michael Stabin, et al.. (1993). Samarium-153-EDTMP biodistribution and dosimetry estimation.. PubMed. 34(7). 1031–6. 168 indexed citations
17.
Powers, William J., Michael Stabin, David Howse, John O. Eichling, & Peter Herscovitch. (1988). Radiation absorbed dose estimates for oxygen-15 radiopharmaceuticals (H2(15)O, C15O, O15O) in newborn infants.. PubMed. 29(12). 1961–70. 5 indexed citations
18.
Lacy, Jeffrey L., Mario S. Verani, Henry B. Wiles, et al.. (1988). An improved tungsten-178/tantalum-178 generator system for high volume clinical applications.. PubMed. 29(9). 1526–38. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026